Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,230.12
+0.3%
+21.11
Arrow-Thin-Down
DJI
49,499.27
-0.3%
-152.87
Arrow-Thin-Down
NASDAQ
25,114.44
+0.9%
+222.13
Arrow-Thin-Down
Bitcoin
$78,282.00
+1.5%
+$1,146.69
Arrow-Thin-Down
AAPL
$280.19
+3.3%
+$8.84
Arrow-Thin-Down
AMZN
$268.26
+1.2%
+$3.20
Arrow-Thin-Down
GOOG
$382.96
+0.3%
+$1.02
Arrow-Thin-Down
META
$608.57
-0.5%
-$3.34
Arrow-Thin-Down
MSFT
$414.40
+1.6%
+$6.62
Arrow-Thin-Down
NVDA
$198.61
-0.5%
-$0.96
Arrow-Thin-Down
TSLA
$390.97
+2.4%
+$9.34
Most Active StocksDaily Stock GainersDaily Stock Losers
Terns Pharmaceuticals logo

Terns Pharmaceuticals

(NASDAQ) TERN

Current Price$52.94
Market Cap$6.11B
Since IPO (2021)+188%
5 Year+141%
1 Year+1,387%
1 Month+0%

Terns Pharmaceuticals Financials at a Glance

Market Cap

$6.11B

Revenue (TTM)

$0.00

Net Income (TTM)

$96.21M

EPS (TTM)

$-1.03

P/E Ratio

-51.26

Dividend

$0.00

Beta (Volatility)

0.90 (Low)

Price

$52.94

Volume

111,236

Open

$52.95

Previous Close

$52.94

Daily Range

$52.93 - $52.95

52-Week Range

$2.65 - $53.19

TERN News

Healthcare professional inspecting charts

Why Terns Pharmaceuticals Stock Rocked the Market in March

Eric VolkmanApr 8, 2026
GettyImages-941740978-1201x801-d21b45d

The Largest Healthcare Companies by Market Cap in April 2026

Lyle DalyApr 6, 2026
SellAlert-Purple.png

As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors?

Jonathan PoncianoMar 23, 2026
SellAlert-Green.png

This Biotech Fund Sold $8 Million of Terns Stock Last Quarter, but Here's Why It Still Seems Very Bullish

Jonathan PoncianoMar 18, 2026
BuyAlert-Red.png

This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally

Jonathan PoncianoMar 16, 2026
BuyAlert-Purple.png

Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing

Jake LerchMar 5, 2026
SellAlert-Purple.png

OrbiMed Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing

Eric TrieFeb 20, 2026
BuyAlert-Blue.png

Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge

Jonathan PoncianoFeb 17, 2026
Page 1

TERN: Motley Fool Moneyball Superscore

65

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Terns Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

59

CEO

Amy L. Burroughs, MBA

Website

www.ternspharma.com

Headquarters

Foster City, CA 94404, US

TERN Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-14%

Return on Capital

-11%

Return on Assets

-9%

Earnings Yield

-1.95%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.11B

Shares Outstanding

115.52M

Volume

111.24K

Avg. Volume

5.66M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$110.12M

EBITDA

$110.12M

Operating Cash Flow

$82.18M

Capital Expenditure

$0.00

Free Cash Flow

$82.18M

Cash & ST Invst.

$1.02B

Total Debt

$919.00K

Terns Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$108.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$6.11B

N/A

Market Cap/Employee

$103.64M

N/A

Employees

59

N/A

Net Income

$23.57M

-8.1%

EBITDA

$34.37M

-33.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.02B

+185.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$445.00K

-51.6%

Short Term Debt

$474.00K

+10.7%

Return on Assets

-9.39%

N/A

Return on Invested Capital

-10.92%

N/A

Free Cash Flow

$19.08M

-30.8%

Operating Cash Flow

$19.08M

-30.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ELVNEnliven Therapeutics, Inc.
$41.70+1.14%
RLAYRelay Therapeutics, Inc.
$12.72-1.85%
INBXInhibrx Biosciences, Inc.
$128.79-0.33%
NKTRNektar Therapeutics
$86.46+1.67%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About TERN

What is the current price of Terns Pharmaceuticals?

Terns Pharmaceuticals is trading at $52.94 per share.

What is the 52-week range for Terns Pharmaceuticals?

Over the past 52 weeks, Terns Pharmaceuticals has traded between $2.66 and $53.19.

How much debt does Terns Pharmaceuticals have?

As of the most recent reporting period, Terns Pharmaceuticals reported total debt of $919,000.

How much cash does Terns Pharmaceuticals have on hand?

Terns Pharmaceuticals reported $524.75M in cash and cash equivalents in its most recent financial results.

What is Terns Pharmaceuticals’s dividend yield?

Terns Pharmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services